Chemical Compound

N-[3-[4,5-Dihydro-4-methyl-6-[[4-(4-morpholinylcarbonyl)phenyl]amino]-5-oxo-2-pyrazinyl]-2-methylphenyl]-4-(1,1-dimethylethyl)benzamide

CAS Registry Number 910232-84-7
N-[3-[4,5-Dihydro-4-methyl-6-[[4-(4-morpholinylcarbonyl)phenyl]amino]-5-oxo-2-pyrazinyl]-2-methylphenyl]-4-(1,1-dimethylethyl)benzamide 结构式
Primary record

N-[3-[4,5-Dihydro-4-methyl-6-[[4-(4-morpholinylcarbonyl)phenyl]amino]-5-oxo-2-pyrazinyl]-2-methylphenyl]-4-(1,1-dimethylethyl)benzamide

库存
5,714 克
纯度
99.7 %
CAS
910232-84-7

化合物标识与属性

CAS
910232-84-7
PubChem CID
24857323
SMILES
CC1=C(C=CC=C1NC(=O)C2=CC=C(C=C2)C(C)(C)C)C3=CN(C(=O)C(=N3)NC4=CC=C(C=C4)C(=O)N5CCOCC5)C
Canonical SMILES
Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1

名称与同义词

  • CGI-1746
  • 910232-84-7
  • CGI1746
  • RefChem:918300
  • D0H3JH
  • MFCD18782602
  • 4-(tert-Butyl)-N-(2-methyl-3-(4-methyl-6-((4-(morpholine-4-carbonyl)phenyl)amino)-5-oxo-4,5-dihydropyrazin-2-yl)phenyl)benzamide
  • CGI 1746
  • SCHEMBL769731
  • GCI1746
  • C34H37N5O4
  • GTPL8066
  • orb1305433
  • CHEMBL1230541
  • SCHEMBL29359902
  • BDBM36516
  • CGI-560
  • CGI-676
  • DTXSID70647724
  • EX-A614
  • SYN1164
  • JIFCFQDXHMUPGP-UHFFFAOYSA-N
  • GLXC-90238
  • HMS3652B20
  • AOB87149
  • BCP05160
  • CGI-1316
  • CGI-2233
  • CGI-2815
  • CGI-3130
  • KS-00001CV0
  • CGI-1746?
  • s7051
  • ZINC58631343
  • AKOS024462679
  • BCP9000510
  • CCG-270125
  • CGI1746, 2
  • CS-0252
  • EBC-220069
  • SB19189
  • NCGC00345857-01
  • NCGC00345857-06
  • NCGC00345857-10
  • AC-35289
  • AK162846
  • AS-16300
  • BC600469
  • CID 24857323
  • DA-34985
  • HY-11999
  • 4-tert-butyl-N-[2-methyl-3-[4-methyl-6-[4-(morpholine-4-carbonyl)anilino]-5-oxopyrazin-2-yl]phenyl]benzamide
  • A3302
  • FT-0700404
  • SW222244-1
  • X3449
  • J2.909.101C
  • A11348
  • F15274
  • W-5786
  • A860630
  • N-[3-[4,5-Dihydro-4-methyl-6-[[4-(4-morpholinylcarbonyl)phenyl]amino]-5-oxo-2-pyrazinyl]-2-methylphenyl]-4-(1,1-dimethylethyl)benzamide
  • Q27075885
  • Btk inhibitors (autoimmune disease/inflammatory disease)
  • B0084-430556
  • N-[3-[4,5-dihydro-4-methyl-6-[[4-(4-morpholinylcarbonyl)phenyl]amino]-5-oxo-2-pyrazinyl]-2-methylphenyl]-4-(tert-butyl)benzamide
  • Btk inhibitors (autoimmune disease/inflammatory disease), Gilead
  • 4-Tert-Butyl-N-[2-Methyl-3-(4-Methyl-6-{[4-(Morpholin-4-Ylcarbonyl)phenyl]amino}-5-Oxo-4,5-Dihydropyrazin-2-Yl)phenyl]benzamide
  • Btk inhibitors (autoimmune disease/inflammatory disease), Cellular Genomics
  • Btk inhibitors (autoimmune disease/inflammatory disease), CGI Pharmaceuticals
  • 4-tert-butyl-N-(2-methyl-3-(4-methyl-6-(4-(morpholine-4-carbonyl)anilino)-5-oxopyrazin-2-yl)phenyl)benzamide
  • 4-tert-butyl-N-(2-methyl-3-(4-methyl-6-(4-(morpholine-4-carbonyl)phenylamino)-5-oxo-4,5-dihydropyrazin-2-yl)phenyl)benzamide
  • 4-tert-butyl-n-(2-methyl-3-{4-methyl-6-[4-(morpholine-4-carbonyl)-phenylamino]-5-oxo-4,5-dihydro-pyrazin-2-yl}-phenyl)-benzamide
  • 4-tert-Butyl-N-(2-methyl-3-{4-methyl-6-[4-(morpholine-4-carbonyl)anilino]-5-oxo-4,5-dihydropyrazin-2-yl}phenyl)benzamide
  • 4-tert-butyl-N-[2-methyl-3-(4-methyl-6-{[4-(morpholine-4-carbonyl)phenyl]amino}-5-oxo-4,5-dihydropyrazin-2-yl)phenyl]benzamide
  • 4-tert-butyl-N-[2-methyl-3-(4-methyl-6-{[4-(morpholine-4-carbonyl)phenyl]amino}-5-oxopyrazin-2-yl)phenyl]benzamide
  • 4-tert-butyl-N-[2-methyl-3-[4-methyl-6-[4-(morpholine-4-carbonyl)anilino]-5-oxo-pyrazin-2-yl]phenyl]benzamide
  • N-[2-Methyl-3-[1-methyl-5-[[4-(morpholinocarbonyl)phenyl]amino]-6-oxo-1,6-dihydropyrazine-3-yl]phenyl]-4-tert-butylbenzamide